India's first dengue vaccine, QDENGA, is set to enter the market in the first half of 2027 under an exclusive partnership between Takeda and Dr Reddy's Laboratories. The agreement will facilitate private-market distribution and awareness ahead of the commercial rollout
India has approved its first dengue vaccine, QDENGA, for individuals aged 4 to 60 years. The DCGI clearance allows vaccination without pre-screening and marks a major step in strengthening dengue prevention alongside surveillance, vector control and public health measures.
